Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2026-02-22 @ 6:47 PM
Study NCT ID:
NCT02497469
Status:
COMPLETED
Last Update Posted:
2020-01-28
First Post:
2015-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-10
First Submit QC Date:
None
Study First Post Date:
2015-07-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-17
Results First Submit QC Date:
None
Results First Post Date:
2019-10-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-14
Last Update Post Date:
2020-01-28
Last Update Post Date Type:
ACTUAL